Analyst Ratings for AcelRx Pharmaceuticals (acrx)
acrx Rating Summary
acrx Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.63 (+437.8%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Avg. $ Target:
$4.63 (+437.8%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2023 | Alliance Global Partners | James Molloy | New Coverage | Buy (N/A) |
4.25 (N/A) |
0.58 (0.86) |
48.28% | Details |
| 8/18/2023 | H.C. Wainwright » Updated 9/25/2023 |
Ed Arce | Upgrade | Buy (Neutral) |
5.00 (8.00) |
0.84 (0.86) |
2.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
